Metabolic signature of the pathogenic 22q11.2 deletion identifies carriers and provides insight into systemic dysregulation
Open Access
- 14 December 2023
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 13 (1) , 1-7
Abstract
Large deletions at chromosome 22q11.2 are known to cause severe clinical conditions collectively known as 22q11.2 deletion syndrome. Notwithstanding the pathogenicity of these deletions, affected individuals are typically diagnosed in late childhood or early adolescence, and little is known of the molecular signaling cascades and biological consequences immediately downstream of the deleted genes. Here, we used targeted metabolomics to compare neonatal dried blood spot samples from 203 individuals clinically identified as carriers of a deletion at chromosome 22q11.2 with 203 unaffected individuals. A total of 173 metabolites were successfully identified and used to inform on systemic dysregulation caused by the genomic lesion and to discriminate carriers from non-carriers. We found 84 metabolites to be differentially abundant between carriers and non-carriers of the 22q11.2 deletion. A predictive model based on all 173 metabolites achieved high Accuracy (89%), Area Under the Curve (93%), F1 (88%), Positive Predictive Value (94%), and Negative Predictive Value (84%) with tyrosine and proline having the highest individual contributions to the model as well as the highest interaction strength. Targeted metabolomics provides insight into the molecular consequences possibly contributing to the pathology underlying the clinical manifestations of the 22q11 deletion and is an easily applicable approach to first-pass screening for carrier status of the 22q11 to prompt subsequent verification of the genomic diagnosis.Keywords
All Related Versions
Funding Information
- Lundbeck Foundation (R102-A9118, R155-2014-1724, R268-2016-3925, R102-A9118, R155-2014-1724, R268-2016-3925, R102-A9118, R155-2014-1724, R268-2016-3925, R155-2014-1724, R268-2016-3925, R102-A9118, R155-2014-1724, R102-A9118, R155-2014-1724)
This publication has 26 references indexed in Scilit:
- Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion SyndromeJournal of Biological Chemistry, 2015
- Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion SyndromeAmerican Journal of Psychiatry, 2014
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Newborn screening programs: Should 22q11 deletion syndrome be added?Genetics in Medicine, 2010
- Proline Affects Brain Function in 22q11DS Children with the Low Activity COMT158 AlleleNeuropsychopharmacology, 2008
- Predictive learning via rule ensemblesThe Annals of Applied Statistics, 2008
- Storage policies and use of the Danish Newborn Screening BiobankJournal of Inherited Metabolic Disease, 2007
- Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndromeHuman Molecular Genetics, 2006
- Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes)Current Opinion in Pediatrics, 2002
- Structure and function of the aromatic amino acid hydroxylasesBiochemical Journal, 1995